Search Results

Massage Therapy
Specialty

Massage Therapy

A leader in pediatric massage therapy, Nationwide Children’s is one of the only children’s hospitals to staff a department of full-time, licensed massage therapists.

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
News

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England Journal of Medicine. The study was conducted by Researchers from Nationwide Children’s Hospital in collaboration with AveXis, Inc. and The Ohio State University College of Medicine.

AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
News

AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

AveXis, Inc., (Nasdaq:AVXS) a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced the U.S.

Spinal Muscular Atrophy Clinic
Specialty

Spinal Muscular Atrophy Clinic

The SMA Clinic is a joint program between Nationwide Children’s and The Ohio State University Wexner Medical Center. Our team provides comprehensive, multidisciplinary care for patients from across the United States.

Becker Muscular Dystrophy
Condition

Becker Muscular Dystrophy

Becker muscular dystrophy is the same basic disease as Duchenne muscular dystrophy, except it is less common and the symptoms are milder and slower to progress. It only affects males. Once symptoms begin, they follow a slower, but similar, course to that of Duchenne muscular dystrophy.

Residency and Fellowship Programs

Residency and Fellowship Programs

Discover the residencies and fellowship programs we offer. 

Article

July 2014

Dr. Scott Harper discusses RNAi silencing in limb girdle muscular dystrophy 1A.

Article

July 2011

Dr. Carsten Bonnemann discusses collagen VI myopathies and a novel cause of ullrich congenital muscular dystrophy.

Article

March 2015

Dr. Jerry Mendell discusses phase 1/2a follistatin gene therapy trial for becker muscular dystrophy. 

Myotonic Muscular Dystrophy

Myotonic muscular dystrophy, also known as MMD or Steinert’s disease, is the most common form of MD in adults.

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion